Literature DB >> 12722794

Immunohistochemical demonstration of nitric oxide synthase (NOS) in the normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas.

Marek Pawlikowski1, Katarzyna Winczyk, Maria Jaranowska.   

Abstract

Nitric oxide synthase (NOS) immunoreactivity was examined in normal rat anterior pituitary glands, estrogen-induced rat pituitary tumors and human pituitary adenomas using a polyclonal antibody reacting with all three isoforms of NOS in both species. It was found that NOS immunorectivity in pituitary glandular cells is stronger in rat experimental pituitary tumors than in normal pituitaries. NOS immunoreactivity is also detectable in all but two human pituitary adenomas and seems to negatively correlate with microvascularization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12722794

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  7 in total

1.  The clinical and pathological significance of nitric oxide synthase in human pituitary adenomas: a comparison with MIB-1.

Authors:  K Onishi; T Kamida; Y Momii; T Abe; M Fujiki
Journal:  Endocrine       Date:  2013-09-06       Impact factor: 3.633

2.  Signaling pathway networks mined from human pituitary adenoma proteomics data.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2010-04-28       Impact factor: 3.063

3.  Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas.

Authors:  Xianquan Zhan; Xiaowei Wang; Ying Long; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2014-12-24       Impact factor: 3.063

Review 4.  Mitochondrial Dysfunction Pathway Networks and Mitochondrial Dynamics in the Pathogenesis of Pituitary Adenomas.

Authors:  Na Li; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-09       Impact factor: 5.555

5.  Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas.

Authors:  Xianquan Zhan; Jiajia Li; Tian Zhou
Journal:  Front Pharmacol       Date:  2021-03-24       Impact factor: 5.810

Review 6.  Architects of Pituitary Tumour Growth.

Authors:  Maria Eugenia Sabatino; Ezequiel Grondona; Ana Lucía De Paul
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

Review 7.  Pituitary adenoma nitroproteomics: current status and perspectives.

Authors:  Xianquan Zhan; Xiaowei Wang; Dominic M Desiderio
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.